We are live on
!
Find out more
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
DOVA
Delisted
DOVA was delisted on the 11th of November, 2019.
60 hedge funds and large institutions have $309M invested in Dova Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
170% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 10
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
12% more capital invested
Capital invested by funds: $275M → $309M (+$33.5M)
9% more funds holding
Funds holding: 55 → 60 (+5)
Holders
60
Holders Change
+5
Holders Change %
+9.09%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
18
Increased
27
Reduced
10
Closed
13
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
+$30K
Top Buyers
| 1 |
BlackRock
New York
|
+$13.5M |
| 2 |
PA
Perceptive Advisors
New York
|
+$9.39M |
| 3 |
NC
Nexthera Capital
New York
|
+$6.87M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.14M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.69M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$11.7M |
| 2 |
FI
Fosun International
Hong Kong,
China
|
-$11.4M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
-$5.91M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.99M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$3.39M |
